These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4177776)

  • 1. Genetic control of dicumarol levels in man.
    Vesell ES; Page JG
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes.
    Atlas SA; Vesell ES; Nebert DW
    Cancer Res; 1976 Dec; 36(12):4619-30. PubMed ID: 63323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
    Vesell ES; Passananti GT; Greene FE; Page JG
    Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
    [No Abstract]   [Full Text] [Related]  

  • 8. Polygenic factors controlling drug response.
    Vesell ES
    Med Clin North Am; 1974 Sep; 58(5):951-63. PubMed ID: 4138463
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of clinical chemical determinations of drug concentrations in biological fluids.
    Vessell ES; Passananti GT
    Clin Chem; 1971 Sep; 17(9):851-66. PubMed ID: 4105897
    [No Abstract]   [Full Text] [Related]  

  • 10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol Chemother; 1969; 7():1-52. PubMed ID: 4195046
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic control of drug levels in man: phenylbutazone.
    Vesell ES; Page JG
    Science; 1968 Mar; 159(3822):1479-80. PubMed ID: 5753556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.
    Vesell ES; Passananti GT; Aurori KC
    Pharmacology; 1975; 13(2):101-11. PubMed ID: 49899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects.
    Bchir F; Dogui M; Ben Fradj R; Arnaud MJ; Saguem S
    C R Biol; 2006 Jul; 329(7):512-9. PubMed ID: 16797457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and caffeine. Influence on prenatal hemodynamics and behavior in early twin pregnancy.
    Huisman M; Risseeuw B; van Eyck J; Arabin B
    J Reprod Med; 1997 Nov; 42(11):731-4. PubMed ID: 9408873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.